MHLW Warns Of Side Effects For Two More Influenza Drugs
This article was originally published in PharmAsia News
Executive Summary
Besides Tamiflu, whose side effects had been previously cautioned, Japan is calling attention to the occurrence of abnormal behaviors in minors taking influenza treatments GlaxoSmithKline's Relenza (zanamivir) and amantadine. Japan's Ministry of Health, Labor and Welfare has received reports of neuropsychiatric events, including patients jumping out of balconies. On Jan. 29, MHLW revised the drugs' package inserts and called physicians' attentions to these side effects. MHLW asked for parental monitoring for at least two days after a minor takes the flu drugs. (Click here for more-Japanese language
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.